Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Ketoreductase Mutation. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN110964703B reveals high-efficiency ketoreductase for duloxetine intermediate. Achieve cost reduction and supply reliability in pharmaceutical manufacturing.